Parkinson’s disease is a complex neurodegenerative disorder that affects millions worldwide, with increasing prevalence as populations age. The market for Parkinson’s disease treatments is expanding rapidly, driven by rising awareness of what Parkinson’s disease is, advancements in research, and improvements in healthcare systems. In 2023, the United States Parkinson’s disease market size was USD 1.8 billion. This growth underscores the rising demand for therapies targeting both the symptoms and progression of the condition. Despite established treatments, significant unmet needs remain, particularly for therapies that address the underlying causes and improve life ex...
